Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether or not the total length of small intestine effects outcomes after bariatric surgery in a cohort of patients preoperatively and up to ten years postoperatively. Roux-en-Y gastric bypass and vertical sleeve gastrectomy will be the surgical groups in this study. We aim to determine if bowel length has a significant effect on long term weight loss or other nutritional deficiencies in this bariatric cohort.
Bariatric surgery (also known as "weight loss surgery") is the most effective treatment for obesity as well as a number of other obesity-related conditions, including type 2 diabetes, hypertension, and hypercholesterolemia. Interestingly, not all patients respond with significant weight loss following surgery and some patients even lack much weight loss at all over the long-term. Even though variability in treatment response is observed in a variety of diseases, the biological basis for this variability in weight loss after bariatric surgery is poorly understood. Recent data from our group as well as others, however, suggest that differences in the total length of the small intestine may significantly contribute to these differences in weight loss over time. For example, Roux-en-Y gastric bypass is thought to exert its weight loss effect because of a bypass of small intestine that causes a degree of nutrient malabsorption. The bypassed small intestine (<100cm) is near the proximal end of the intestines closest to the stomach. Hypothetically, an individual with the greater total small intestine length may not benefit as much from the bypass as someone who has a much shorter length of total small intestine. Whether or not this hypothetical relationship is true remains unknown, but a recent study demonstrated that small intestine length does differ significantly between individuals with lengths ranging from 300cm to >1200cm. The total length of small intestine is not routinely measured during any bariatric procedure, as the lengths of the bypass limbs are determined from the portion of the intestines closest to the stomach. The purpose of this study is to determine whether the amount of total small intestine significantly affects weight loss in patients undergoing bariatric surgery - both the Roux-en-Y gastric bypass (RYGB) or the Vertical Sleeve Gastrectomy (VSG). If there is a significant effect of total small intestine length on long-term weight loss in bariatric patients, then it would justify the conduct of a further study to determine whether or not these operations should be performed differently in individuals to account for the differences in small intestine length. This is an observational study that will be looking at body weight (primary endpoint) and other nutritional endpoints (other pre-specified outcome measure) over time up to ten years in this patient cohort. The body weight measurements and any laboratory data will be collected that are part of the routine clinical care of these patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RYGB | Roux-en-Y Gastric Bypass - these are patients that undergo a Roux-en-Y gastric bypass operation for their bariatric operation. |
| |
| VSG | Vertical Sleeve Gastrectomy - these are patients that undergo a vertical sleeve gastrectomy operation for their bariatric operation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Small bowel length measurement | Procedure | The total length of the small bowel with be measured at the time of the bariatric surgical operation. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Body Weight | Body weight will be measured preoperatively (within 30 days of the operation) as the baseline body weight, then postoperatively up to ten years from the time of initial surgery. Measurements will be made per routine clinical care and not solely for research purposes. Exact time points before and after surgery that body weight will be measured, except for the day of surgery, will differ between patients in the study. Change in body weight over time will be measured annually, adjusted for baseline body weight at the time of surgery. Regression will be used to test for a significant interaction of "total bowel length" and "body weight" over time in the patient cohorts (RYGB vs. VSG) - this is our primary outcome measurement. We are examining whether there is a significant interaction between any change in body weight over time and the small bowel length in the patient cohorts. | Up to 10 years postoperatively as measured for routine clinical care |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Vitamin A | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
We will be studying two cohorts of patients prior to and following either Roux-en-Y gastric bypass or vertical sleeve gastrectomy for up to ten years.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Charles R Flynn, PhD | Vanderbilt University Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40146457 | Result | Albaugh VL, Weinberg JL, Yu D, Spann MD, Williams DB, Samuels JM, Flynn CR, English WJ. Total Alimentary Limb Length Is Not Associated with Weight Loss Following Proximal Roux-en-Y Gastric Bypass. Obes Surg. 2025 May;35(5):1693-1701. doi: 10.1007/s11695-025-07817-5. Epub 2025 Mar 27. |
| Label | URL |
|---|---|
| Total Alimentary Limb Length Is Not Associated with Weight Loss Following Proximal Roux-en-Y Gastric Bypass | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D044342 | Malnutrition |
| D009765 | Obesity |
| D015431 | Weight Loss |
| ID | Term |
|---|---|
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D050177 | Overweight |
| D044343 | Overnutrition |
Not provided
Not provided
Not provided
Not provided
Not provided
| Up to 10 years postoperatively |
| Vitamin D | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Vitamin E | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Vitamin B1 | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Vitamin B2 | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Vitamin B6 | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Vitamin B12 | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Iron | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Parathyroid Hormone | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Total Iron Binding Capacity | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| Ferritin | Other pre-specified outcomes will be analyzed annually, adjusted for baseline measurements. Similar to the primary endpoint, data will be analyzed as continuous variables and tested for an interaction between total bowel length and the nutritional variable of interest. These other nutritional outcomes will vary depending on the clinical course of the individual patients in this observational study. Thus, time points that patients will have these variables measured will not be exactly the same across patients and will depend on the clinical care of the individual patient. | Up to 10 years postoperatively |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001836 | Body Weight Changes |